Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.960
-0.210 (-5.04%)
Jun 4, 2025, 1:11 PM - Market open

Jaguar Health Statistics

Total Valuation

Jaguar Health has a market cap or net worth of $5.01 million. The enterprise value is $37.69 million.

Market Cap 5.01M
Enterprise Value 37.69M

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

Jaguar Health has 1.26 million shares outstanding. The number of shares has increased by 934.82% in one year.

Current Share Class 1.26M
Shares Outstanding 1.26M
Shares Change (YoY) +934.82%
Shares Change (QoQ) +31.57%
Owned by Insiders (%) 8.45%
Owned by Institutions (%) 5.53%
Float 1.02M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.15
Forward PS 0.33
PB Ratio 1.58
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.26
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 11.56.

Current Ratio 1.08
Quick Ratio 0.25
Debt / Equity 11.56
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -459.52% and return on invested capital (ROIC) is -44.79%.

Return on Equity (ROE) -459.52%
Return on Assets (ROA) -37.48%
Return on Invested Capital (ROIC) -44.79%
Return on Capital Employed (ROCE) -137.78%
Revenue Per Employee $235,755
Profits Per Employee -$810,816
Employee Count 49
Asset Turnover 0.22
Inventory Turnover 0.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -96.05% in the last 52 weeks. The beta is 0.96, so Jaguar Health's price volatility has been similar to the market average.

Beta (5Y) 0.96
52-Week Price Change -96.05%
50-Day Moving Average 6.55
200-Day Moving Average 19.99
Relative Strength Index (RSI) 32.98
Average Volume (20 Days) 110,564

Short Selling Information

The latest short interest is 32,263, so 2.55% of the outstanding shares have been sold short.

Short Interest 32,263
Short Previous Month 114,446
Short % of Shares Out 2.55%
Short % of Float 3.15%
Short Ratio (days to cover) 0.14

Income Statement

In the last 12 months, Jaguar Health had revenue of $11.55 million and -$39.73 million in losses. Loss per share was -$93.55.

Revenue 11.55M
Gross Profit 9.51M
Operating Income -32.04M
Pretax Income -38.32M
Net Income -39.73M
EBITDA -30.16M
EBIT -32.04M
Loss Per Share -$93.55
Full Income Statement

Balance Sheet

The company has $5.69 million in cash and $38.34 million in debt, giving a net cash position of -$32.65 million or -$25.81 per share.

Cash & Cash Equivalents 5.69M
Total Debt 38.34M
Net Cash -32.65M
Net Cash Per Share -$25.81
Equity (Book Value) 3.32M
Book Value Per Share 2.64
Working Capital 2.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.65 million and capital expenditures -$16,000, giving a free cash flow of -$29.67 million.

Operating Cash Flow -29.65M
Capital Expenditures -16,000
Free Cash Flow -29.67M
FCF Per Share -$23.46
Full Cash Flow Statement

Margins

Gross Margin 82.34%
Operating Margin -277.33%
Pretax Margin -350.41%
Profit Margin n/a
EBITDA Margin -261.07%
EBIT Margin -277.33%
FCF Margin n/a

Dividends & Yields

Jaguar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -934.82%
Shareholder Yield -934.82%
Earnings Yield -787.36%
FCF Yield -587.97%

Analyst Forecast

The average price target for Jaguar Health is $60.00, which is 1,415.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target $60.00
Price Target Difference 1,415.15%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.04:1.

Last Split Date Mar 24, 2025
Split Type Reverse
Split Ratio 0.04:1

Scores

Altman Z-Score n/a
Piotroski F-Score 4